Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.6K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.6K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

853
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
853
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

Prostate cancer and prostatic diseases·2026
Same author

Sentinel Physicians for the Environment: A Chilean Perspective to Address Global Health and Climate Resilience.

International journal of environmental research and public health·2026
Same author

Poorly differentiated neuroendocrine transformation from metastatic upper tract urothelial carcinoma.

BMJ case reports·2026
Same author

A plain language summary of the TROPiCS-04 study: sacituzumab govitecan use after platinum-based chemotherapy and immunotherapy in people with locally advanced or metastatic cancer of the bladder, urethra, or upper urinary tract.

Future oncology (London, England)·2025
Same author

Balancing risks and benefits of immune checkpoint inhibitors in patients with pre-existing immune-mediated inflammatory diseases: A comprehensive review.

Critical reviews in oncology/hematology·2025
Same author

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.

The New England journal of medicine·2025

Related Experiment Video

Updated: Apr 16, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

[Prostate cancer].

Joan Morote1, Xavier Maldonado2, Rafael Morales-Bárrera3

  • 1Servicio de Urología, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España.

Medicina Clinica
|March 3, 2015
PubMed
Summary
This summary is machine-generated.

Recent prostate cancer (PC) management advances include improved screening reducing mortality and active surveillance for non-aggressive tumors. New markers and multiparametric MRI enhance diagnosis and staging, while robotic surgery and modern radiotherapy improve treatment efficacy and reduce side effects.

Keywords:
Cáncer de próstataDiagnosisDiagnósticoProstate cancerTratamientoTreatment

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

15.4K

Related Experiment Videos

Last Updated: Apr 16, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

15.4K

Area of Science:

  • Oncology
  • Urology
  • Radiology

Background:

  • Prostate cancer (PC) remains a significant health concern.
  • Advances in screening and diagnostics are crucial for early detection and effective management.
  • Multidisciplinary approaches are essential for optimizing patient outcomes.

Purpose of the Study:

  • To review recent advancements in prostate cancer management.
  • To highlight innovations in diagnostics, treatment, and monitoring.
  • To provide an overview of the current landscape of prostate cancer care.

Main Methods:

  • Review of recent literature and clinical studies on prostate cancer management.
  • Analysis of emerging diagnostic tools, including novel biomarkers and multiparametric MRI (mMRI).
  • Evaluation of technological improvements in radical prostatectomy (RP) and radiotherapy (RT), and systemic therapies.

Main Results:

  • Screening studies demonstrate reduced PC mortality.
  • Active surveillance is a viable option for non-aggressive cancers.
  • Multiparametric MRI (mMRI) and fusion biopsy techniques improve diagnostic accuracy and staging.
  • Robotic surgery and modern radiotherapy enhance treatment efficacy and reduce morbidity.
  • New hormonal therapies show efficacy in metastatic castration-resistant prostate cancer.

Conclusions:

  • Current advancements in diagnostics and treatment offer improved outcomes for prostate cancer patients.
  • Personalized approaches, including active surveillance and targeted therapies, are becoming standard.
  • Technological innovations in surgery and radiation therapy are minimizing treatment-related toxicity.
  • Management of advanced and metastatic prostate cancer continues to evolve with novel therapeutic options.